Understanding Levothyroxine and Subclinical Hypothyroidism
Myth: Levothyroxine Can Treat Subclinical Hypothyroidism
The claim that levothyroxine, a synthetic alternative to natural thyroid hormone, can effectively treat subclinical hypothyroidism is incorrect.
Truth: Limited Effectiveness of Levothyroxine
Research published in The New England Journal of Medicine indicates that levothyroxine does not successfully address subclinical hypothyroidism. In this condition, the thyroid gland fails to produce sufficient thyroid hormone, which is crucial for various bodily functions, including weight regulation, metabolism, bone growth, neuron development, and heat production. Common symptoms of hypothyroidism include weight gain, fatigue, cold intolerance, and depression. However, individuals with subclinical hypothyroidism often exhibit few or no symptoms.
Levothyroxine’s Role in Hypothyroidism Treatment
Levothyroxine is widely utilized as a treatment for hypothyroidism due to its synthetic formulation of the thyroid hormone. Despite its common use, its effectiveness in managing subclinical hypothyroidism remains uncertain. A study led by Scott and colleagues investigated levothyroxine’s impact on this condition.
Study Findings
In this study, 737 adults diagnosed with subclinical hypothyroidism were randomly assigned to receive either levothyroxine or a placebo. While those receiving levothyroxine showed an increase in thyroid hormone production compared to the placebo group, no significant differences were observed in symptoms, quality of life, or overall health status between the two groups. Researchers proposed that higher doses of levothyroxine might offer potential benefits for patients suffering from subclinical hypothyroidism.
Reference
Stott DJ, Rodondi N, Kearney PM, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017;376(26):2534-2544. doi:10.1056/NEJMoa1603825.